Cargando…
Hydroxamic Acids Containing a Bicyclic Pinane Backbone as Epigenetic and Metabolic Regulators: Synergizing Agents to Overcome Cisplatin Resistance
SIMPLE SUMMARY: Chemotherapy is one of the most widely used cancer treatments. A significant barrier to its successful use is the high risk of acquiring the phenomenon of multidrug resistance in cancer. In this regard, today, researchers’ attention is focused on solving this critically important pro...
Autores principales: | Aleksandrova, Yulia, Munkuev, Aldar, Mozhaitsev, Evgenii, Suslov, Evgeniy, Volcho, Konstantin, Salakhutdinov, Nariman, Neganova, Margarita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605847/ https://www.ncbi.nlm.nih.gov/pubmed/37894352 http://dx.doi.org/10.3390/cancers15204985 |
Ejemplares similares
-
Elaboration of the Effective Multi-Target Therapeutic Platform for the Treatment of Alzheimer’s Disease Based on Novel Monoterpene-Derived Hydroxamic Acids
por: Aleksandrova, Yulia, et al.
Publicado: (2023) -
Novel Multitarget Hydroxamic Acids with a Natural Origin CAP Group against Alzheimer’s Disease: Synthesis, Docking and Biological Evaluation
por: Neganova, Margarita, et al.
Publicado: (2021) -
Novel Tdp1 Inhibitors Based on Adamantane Connected with Monoterpene Moieties via Heterocyclic Fragments
por: Munkuev, Aldar A., et al.
Publicado: (2021) -
Monoterpenoid Epoxidiol Ameliorates the Pathological Phenotypes of the Rotenone-Induced Parkinson’s Disease Model by Alleviating Mitochondrial Dysfunction
por: Aleksandrova, Yulia, et al.
Publicado: (2023) -
New Myrtenal–Adamantane Conjugates Alleviate Alzheimer’s-Type Dementia in Rat Model
por: Dragomanova, Stela, et al.
Publicado: (2022)